syndros Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Syndros, and when can generic versions of Syndros launch?
Syndros is a drug marketed by Benuvia Operations and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
This drug has four patent family members in four countries.
The generic ingredient in SYNDROS is dronabinol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dronabinol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Syndros
A generic version of syndros was approved as dronabinol by SVC PHARMA on June 27th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for syndros?
- What are the global sales for syndros?
- What is Average Wholesale Price for syndros?
Summary for syndros
International Patents: | 4 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Clinical Trials: | 3 |
Patent Applications: | 4,112 |
Drug Prices: | Drug price information for syndros |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for syndros |
What excipients (inactive ingredients) are in syndros? | syndros excipients list |
DailyMed Link: | syndros at DailyMed |
![syndros drug patent expirations Drug patent expirations by year for syndros](/p/graph/s/t/syndros-patent-expirations.png)
![Drug Prices for syndros](/p/graph/drug-price/syndros.png)
Recent Clinical Trials for syndros
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | Phase 1 |
National Institute on Drug Abuse (NIDA) | Phase 1 |
Jeffrey L Gum MD | Phase 4 |
Pharmacology for syndros
Drug Class | Cannabinoid |
Paragraph IV (Patent) Challenges for SYNDROS
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SYNDROS | Oral Solution | dronabinol | 5 mg/mL | 205525 | 1 | 2017-04-17 |
US Patents and Regulatory Information for syndros
syndros is protected by four US patents.
Patents protecting syndros
Oral cannabinoid formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Oral cannabinoid formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Liquid cannabinoid formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Oral cannabinoid formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Benuvia Operations | SYNDROS | dronabinol | SOLUTION;ORAL | 205525-001 | Mar 23, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Benuvia Operations | SYNDROS | dronabinol | SOLUTION;ORAL | 205525-001 | Mar 23, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Benuvia Operations | SYNDROS | dronabinol | SOLUTION;ORAL | 205525-001 | Mar 23, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Benuvia Operations | SYNDROS | dronabinol | SOLUTION;ORAL | 205525-001 | Mar 23, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for syndros
See the table below for patents covering syndros around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2009020666 | ⤷ Sign Up | |
European Patent Office | 2184983 | FORMULATIONS LIQUIDES À USAGE ORAL DE CANNABINOÏDES ET PROCÉDÉS DE TRAITEMENT AVEC CELLES-CI (ORAL CANNABINOID LIQUID FORMULATIONS AND METHODS OF TREATMENT) | ⤷ Sign Up |
Japan | 2010535774 | ⤷ Sign Up | |
Canada | 2698752 | FORMULATIONS LIQUIDES A USAGE ORAL DE CANNABINOIDES ET PROCEDES DE TRAITEMENT AVEC CELLES-CI (ORAL CANNABINOID LIQUID FORMULATIONS AND METHODS OF TREATMENT) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |